When discussing public health campaigns and disease prevention, most people want to immediately jump to the solution – we want a vaccine, a cure, a narrative – so we can stop the cycle of disease and suffering. But we must remember to crawl before we walk, and this cliché could not ring more true than in the world of disease monitoring and surveillance, particularly for a disease like pneumococcal, a deadly bacterial infection that kills more than 1.6 million people annually, including half a million children.
Since our founding in 1993, the Sabin Vaccine Institute (Sabin) has been at the forefront of efforts to control, treat and eliminate vaccine-preventable and neglected tropical diseases by developing new vaccines, advocating the use of existing vaccines and promoting increased access to affordable medical treatments. This year marks our 20th anniversary and gives us reason to celebrate our success in advancing this mission.
Earlier this month, the Coalition against Typhoid (CaT), along with partners at the Bangladesh Pediatric Association, the International Vaccine Institute andthe International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), convened the 8th International Conference on Typhoid Fever and Other Invasive Salmonelloses in Dhaka, Bangladesh. Researchers and health professionals, as well as local, national and international policy makers were in attendance.
From 19-22 February 2013, Sabin Executive Vice-President Dr. Ciro de Quadros and Program Officer Brian Shaw participated in the SEARO Regional Consultation on Measles Elimination and Rubella/CRS Control, held in Kathmandu, Nepal. As a member of the Measles Rubella Initiative (MRI), Sabin is committed to the elimination of measles, rubella & congenital rubella syndrome (CRS).

Pages